OLIGOPEPTIDE-139
OLIGOPEPTIDE-139 is a cosmetic ingredient classified as Skin Conditioning.. No specific regulations have been found across 26 tracked markets.
Also Known As
Market Overview — 29 Markets
Detailed Regulations
EuropeNo restrictions
No specific restrictions for OLIGOPEPTIDE-139 in European Union, United Kingdom.
AmericasNo restrictions
No specific restrictions for OLIGOPEPTIDE-139 in United States, California, Maryland, Washington, Canada, Brazil.
East Asia & OceaniaNo restrictions
No specific restrictions for OLIGOPEPTIDE-139 in South Korea, Japan, Taiwan, Australia.
ASEANNo restrictions
No specific restrictions for OLIGOPEPTIDE-139 in Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines.
GCCNo restrictions
No specific restrictions for OLIGOPEPTIDE-139 in UAE, Saudi Arabia, Qatar, Oman, Kuwait, Bahrain.
EAEUNo restrictions
No specific restrictions for OLIGOPEPTIDE-139 in Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan.
Frequently Asked Questions
Is OLIGOPEPTIDE-139 banned in any country?
OLIGOPEPTIDE-139 is not banned in any of the 26 markets tracked by Formpli. However, it may be subject to restrictions or conditions of use in some markets.
What are the restrictions on OLIGOPEPTIDE-139 in cosmetics?
OLIGOPEPTIDE-139 has no specific restrictions in any of the 26 markets tracked by Formpli. It can generally be used in cosmetic formulations, subject to local general cosmetic regulations.
Can I use OLIGOPEPTIDE-139 in cosmetics?
OLIGOPEPTIDE-139 has no specific regulations in any of the 26 markets tracked by Formpli. Use our free screening tool to verify your complete formula before exporting.
Screen OLIGOPEPTIDE-139 with your full formula
Paste your entire ingredient list and get a compliance report across 26 markets — free, no signup.
Check Ingredients FreeThis information is for reference only and does not constitute legal or regulatory advice. Regulations change — always verify with official sources and consult a regulatory specialist before exporting cosmetic products. Data sourced from EU COSING, US FDA, Health Canada, MHLW Japan, MFDS Korea, ASEAN ACD, GCC SFDA, TGA Australia, ANVISA Brazil, EAEU TR CU, and Taiwan TFDA.